Issue: June 2018
June 07, 2018
1 min read
Save

Trial Scorecard: POINT

Issue: June 2018
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Comparison of aspirin plus clopidogrel vs. aspirin alone for reduction of recurrent stroke in patients with transient ischemic attack or minor ischemic stroke.

Trial Scorecard: POINT